MRS. ROBIN S DACOSTA MD NPI 1730306507

NPI Details

MRS. Robin S Dacosta, MD is an internal medicine in Ronkonkoma, NY with 37 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. MRS. Robin S Dacosta, MD NPI is 1730306507. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1989

The provider's business location address is:

217 PORTION RD
RONKONKOMA, NY
ZIP 11779-341
Phone: (631) 758-3100
Fax: (631) 758-3168

The NPI 1730306507 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Magnesium level (HCPCS:83735)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroid hormone evaluation (HCPCS:84479)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Hemoglobin a1c level (HCPCS:83036)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Vitamin d-3 level (HCPCS:82306)
• Folic acid level, serum (HCPCS:82746)
• Uric acid level, blood (HCPCS:84550)
• Urinalysis, manual test (HCPCS:81002)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Red blood count, manual test (HCPCS:85044)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Phosphate level (HCPCS:84100)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Blood test, clotting time (HCPCS:85610)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Amylase (enzyme) level (HCPCS:82150)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Protein measurement, serum (HCPCS:84165)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood glucose (sugar) level (HCPCS:82947)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Assessment of and care planning for impaired thought processing, typically 50 minutes (HCPCS:99483)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Acute hepatitis panel (HCPCS:80074)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Liver function blood test panel (HCPCS:80076)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Rheumatoid factor level (HCPCS:86431)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)

The enumeration date for this NPI number is 4/20/2007 and was last updated on 4/2/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.